Inspire Advisors, LLC Dynavax Technologies Corp Transaction History

Inspire Advisors, LLC

  • $737 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$12.64 - $14.99 $582,767 - $691,113
-46,105 Reduced 52.78%
41,244 $609,000
Q2 2023

Jul 31, 2023
BUY
$9.85 - $13.17 $58,607 - $78,361
5,950 Added 7.31%
87,349 $1.13 Million
Q1 2023

Apr 24, 2023
BUY
$9.44 - $11.88 $768,406 - $967,020
81,399 New
81,399 $798,000
Q1 2021

Apr 30, 2021
SELL
$4.57 - $11.18 $507 - $1,240
-111 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$3.73 - $5.6 $414 - $621
111 New
111 $0

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email